Commons K. G. and Valentino R. J. (2002) Cellular basis for the effects
of substance P in the periaqueductal gray and dorsal raphe nucleus.
J. Comp. Neurol. 447, 82–97.
Compan V., Salin P. and Daszuta A. (1997) Selective effects of partial
and severe lesions of the serotonergic systems on Met-enkephalin
and substance P neurons in rat basal ganglia. Brain Res. Mol. Brain
Res. 50, 246–256.
Conley R. K., Cumberbatch M. J. et al. (2002) Substance P (neurokinin
1) receptor antagonists enhance dorsal raphe neuronal activity.
J. Neurosci. 22, 7730–7736.
De Felipe C., Herrero J. F., O'Brien J. A., Palmer J. A., Doyle C. A.,
Smith A. J., Laird J. M., Belmonte C., Cervero F. and Hunt S. P.
(1998) Altered nociception, analgesia and aggression in mice
lacking the receptor for substance P. Nature 392, 394–397.
Froger N., Gardier A. M., Moratalla R., Alberti I., Lena I., Boni C., De
Felipe C., Rupniak N. M., Hunt S. P., Jacquot C. et al. (2001)
5-Hydroxytryptamine (5-HT) 1A autoreceptor adaptive changes in
substance P (neurokinin 1) receptor knock-out mice mimic antidepressant-induced desensitization. J. Neurosci. 21, 8188–8197.
Gardner C. J., Armour D. R., Beattie D. T., Gale J. D., Hawcock A. B.,
Kilpatrick G. J., Twissell D. J. and Ward P. (1996) GR205171: a
novel antagonist with high affinity for the tachykinin NK1 receptor,
and potent broad-spectrum anti-emetic activity. Regul. Pept. 65,
45–53.
Haddjeri N. and Blier P. (2000) Effect of neurokinin-I receptor antagonists on the function of 5-HT and noradrenaline neurons. Neuroreport 11, 1323–1327.
Haddjeri N. and Blier P. (2001) Sustained blockade of neurokinin-1
receptors enhances serotonin neurotransmission. Biol. Psychiatry
50, 191–199.
Harlan R. E., Garcia M. M. and Krause J. E. (1989) Cellular localization
of substance P- and neurokinin A-encoding preprotachykinin
mRNA in the female rat brain. J. Comp. Neurol. 287, 179–212.
Hervas I., Vilaro M. T., Romero L., Scorza M. C., Mengod G. and
Artigas F. (2001) Desensitization of 5-HT(1A) autoreceptors by a
low chronic fluoxetine dose effect of the concurrent administration
of WAY-100635. Neuropsychopharmacology 24, 11–20.
Hjorth S. and Auerbach S. B. (1994) Further evidence for the importance
of 5-HT1A autoreceptors in the action of selective serotonin
reuptake inhibitors. Eur. J. Pharmacol. 260, 251–255.
Hof P. R., Young W. G., Bloom F. E., Belichenko P. V. and Celio M. R.
(2000) Mouse Brains. Comparative Cytoarchitectonic Atlas of the
C57BL/6 and 129/SV, CD-Rom. Elsevier Science, Amsterdam.
Kramer M. S., Cutler N., Feighner J. et al. (1998) Distinct mechanism
for antidepressant activity by blockade of central substance P
receptors. Science 281, 1640–1645.
Lejeune F., Gobert A. and Millan M. J. (2002) The selective neurokinin
(NK)(1) antagonist, GR205,171, stereospecifically enhances mesocortical dopaminergic transmission in the rat: a combined dialysis
and electrophysiological study. Brain Res. 935, 134–139.
Lejune F., Gobert A. and Millan M. J. (2003) The neurokinin (NK)1
agonist GR205, 171, alters the influence of serotonin (5-HT)
reuptake inhibitors (SSRIs) on serotonergic neurones: a dual
electrophysiological and microdialysis analysis. Neurosci. 29,
Abstract 889.22.
Liu H. L., Cao R., Jin L. and Chen L. W. (2002) Immunocytochemical
localization of substance P receptor in hypothalamic oxytocincontaining neurons of C57 mice. Brain Res. 948, 175–179.
Maggi C. A., Patacchini R., Rovero P. and Giachetti A. (1993) Tachykinin receptors and tachykinin receptor antagonists. J. Auton.
Pharmacol. 13, 23–93.
Malagie I., Trillat A. C., Douvier E., Anmella M. C., Dessalles M. C.,
Jacquot C. and Gardier A. M. (1996) Regional differences in the
effect of the combined treatment of WAY 100635 and fluoxetine:
